ロード中...
Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma
SIMPLE SUMMARY: Hepatocellular carcinoma is the most common liver malignancy. In the population with an advanced stage of the disease, outcomes could be disappointed by treating with molecular targeting agents because of low treatment response rates. It has gained improving effects of immune checkpo...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036568/ https://ncbi.nlm.nih.gov/pubmed/33807219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071607 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|